The entity has a beta of 0.0, which indicates not very significant fluctuations relative to the market. the returns on MARKET and Theraclion are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak
Strong
Over the last 90 days Theraclion SA has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable forward indicators, Theraclion is not utilizing all of its potentials. The latest stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
Begin Period Cash Flow
2.3 M
Total Cashflows From Investing Activities
-524.5 K
Free Cash Flow
-4 M
Theraclion
Theraclion Relative Risk vs. Return Landscape
If you would invest 0.02 in Theraclion SA on November 15, 2025 and sell it today you would earn a total of 0.00 from holding Theraclion SA or generate 0.0% return on investment over 90 days. Theraclion SA is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded pink sheets are less volatile than Theraclion, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days.
Expected Return
Risk
Theraclion Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Theraclion for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Theraclion SA can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Theraclion SA generated a negative expected return over the last 90 days
Theraclion SA has some characteristics of a very speculative penny stock
The company reported the revenue of 1.48 M. Net Loss for the year was (3.76 M) with loss before overhead, payroll, taxes, and interest of (1.4 M).
Theraclion generates negative cash flow from operations
About 23.0% of the company outstanding shares are owned by corporate insiders
Theraclion Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Theraclion Pink Sheet often depends not only on the future outlook of the current and potential Theraclion's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Theraclion's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding
22.7 M
Shares Float
19.7 M
Theraclion Fundamentals Growth
Theraclion Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Theraclion, and Theraclion fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Theraclion Pink Sheet performance.
By analyzing Theraclion's fundamental ratios, stakeholders can gain valuable insights into Theraclion's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Theraclion has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Theraclion has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Theraclion SA develops echotherapy solutions using high intensity focused ultrasound system. The company was incorporated in 2004 and is based in Malakoff, France. Theraclion operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 24 people.
Things to note about Theraclion SA performance evaluation
Checking the ongoing alerts about Theraclion for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Theraclion SA help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Theraclion SA generated a negative expected return over the last 90 days
Theraclion SA has some characteristics of a very speculative penny stock
The company reported the revenue of 1.48 M. Net Loss for the year was (3.76 M) with loss before overhead, payroll, taxes, and interest of (1.4 M).
Theraclion generates negative cash flow from operations
About 23.0% of the company outstanding shares are owned by corporate insiders
Evaluating Theraclion's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Theraclion's pink sheet performance include:
Analyzing Theraclion's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Theraclion's stock is overvalued or undervalued compared to its peers.
Examining Theraclion's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
Evaluating Theraclion's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Theraclion's management team can help you assess the Company's leadership.
Pay attention to analyst opinions and ratings of Theraclion's pink sheet. These opinions can provide insight into Theraclion's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Theraclion's pink sheet performance is not an exact science, and many factors can impact Theraclion's pink sheet market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
Complementary Tools for Theraclion Pink Sheet analysis
When running Theraclion's price analysis, check to measure Theraclion's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Theraclion is operating at the current time. Most of Theraclion's value examination focuses on studying past and present price action to predict the probability of Theraclion's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Theraclion's price. Additionally, you may evaluate how the addition of Theraclion to your portfolios can decrease your overall portfolio volatility.